Close Menu

NEW YORK – The US Food and Drug Administration on Wednesday provided new guidance for the validation of molecular and antigen tests to be used outside of laboratories for the diagnosis of SARS-CoV-2 infection.

The guidance follows updates on pooled, multi-analyte, and point-of-care testing Emergency Use Authorization submissions published by the agency earlier this week.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.